*2.2.1 Seizures*

The first clinical effect of neurofeedback was the reduction of seizure incidence, duration, and severity in cats, which was then recapitulated in humans [65–67]. This original protocol, which trains the so-called sensorimotor rhythm (SMR), which was originally developed for cats, is still used for the treatment of seizures in humans today, but the seizure-reduction benefits are not exclusive to that method and can be achieved using other forms of neurofeedback, as well [63, 68, 69]. Furthermore, the method is generally the same no matter what kind of seizures the subject has, including psychogenic non-epileptic seizures (PNES), unless it's a focal seizure, which could require specific electrode placements to target the focus [68, 69, personal experience].
